24 Jun 2026

Technical guide on the use of maternal vaccine and long-acting monoclonal antibodies against respiratory syncytial virus to protect infants

In the Region of the Americas, respiratory syncytial virus (RSV) contributes significantly to the burden of respiratory disease, accounting for a high number of hospitalizations, particularly among infants younger than 2 years of age. This publication provides comprehensive, evidence-based recommendations for the use of the maternal RSVpreF…